Mettler-Toledo International, Inc.
MTD Healthcare Diagnostics & Research
Mettler-Toledo International, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.0 billion, up 3.98% from fiscal 2024. In the quarter to June 2026, revenue grew 4.48%, EPS grew 18.3%, free cash flow grew 33.0% and total debt fell 3.29%, each against the same quarter a year earlier. Member of the S&P 500.
Follow MTD
Mettler-Toledo International, Inc. (MTD) EBITDA
Mettler-Toledo International, Inc.'s EBITDA for fiscal 2025 was $1.2B, unchanged from fiscal 2024. Over the twelve months to 30 June 2026 it was $1.3B. Over the past ten years it has ranged from $565.2M (fiscal 2015) to $1.3B (fiscal 2024); the current reading is higher than 91% of that period. Mettler-Toledo International, Inc. ranks 8th of 52 Diagnostics & Research companies by EBITDA.
EBITDA, annual
Embed this chart
Annual newest first
| Period | EBITDA | Change |
|---|---|---|
| FY2025 | $1.2B | (0.49%) |
| FY2024 | $1.3B | 4.12% |
| FY2023 | $1.2B | (3.10%) |
| FY2022 | $1.2B | 12.37% |
| FY2021 | $1.1B | 24.93% |
| FY2020 | $882.8M | 8.04% |
| FY2019 | $817.1M | 6.43% |
| FY2018 | $767.7M | 11.90% |
| FY2017 | $686.0M | 13.22% |
| FY2016 | $605.9M | 7.21% |
Quarterly newest first
| Period | EBITDA | Change |
|---|---|---|
| Jun 2026 | $347.2M | 33.86% |
| Mar 2026 | $259.4M | (31.04%) |
| Dec 2025 | $376.1M | 16.57% |
| Sep 2025 | $322.6M | 8.94% |
| 42 more quarters | Free account |
Against its own ten years
EBITDA against peers
| Company | EBITDA |
|---|---|
| IQV IQVIA Holdings Inc. compare | $3.4B |
| DGX Quest Diagnostics Incorporated compare | $2.2B |
| LH Labcorp Holdings Inc. compare | $2.2B |
| A Agilent Technologies, Inc. compare | $1.9B |
| IDXX IDEXX Laboratories, Inc. compare | $1.6B |
| MTD Mettler-Toledo International, Inc. | $1.3B |
| ILMN Illumina, Inc. compare | $1.2B |
| WAT Waters Corporation compare | $942.8M |
| GH Guardant Health, Inc. compare | −$444.9M |
What EBITDA is
EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.
Reported line item
More on MTD
- Revenue
- Net income
- EPS (diluted)
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement